For central nervous system (CNS) applications, attempts are being made to deliver AAV gene therapy directly to the brain parenchyma or the cerebrospinal fluid (CSF) space by intra-cisterna magna ...

Discrepancies in causes of death were found when reviewing medical records vs death certificate data among patients with AAV.